Fournel, Pierre <br/><br/>
Induction or consolidation chemotherapy for unresectable stage III non-small-cell lung cancer patients treated with concurrent chemoradiation: a randomised phase II trial GFPC - IFCT 02-01.  [electronic resource] 

 -  European journal of cancer (Oxford, England : 1990)  Jan 2016 
 - 181-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1879-0852 
<br/><br/><label>Standard No.: </label>10.1016/j.ejca.2015.10.072  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Carcinoma, Non-Small-Cell Lung--mortality<br/>Chemoradiotherapy--adverse effects<br/>Cisplatin--therapeutic use<br/>Consolidation Chemotherapy--adverse effects<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Induction Chemotherapy--adverse effects<br/>Lung Neoplasms--mortality<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Paclitaxel--therapeutic use<br/>Radiotherapy Dosage<br/>Risk Factors<br/>Survival Analysis<br/>Time Factors<br/>Treatment Outcome<br/>Vinblastine--analogs & derivatives<br/>Vinorelbine